Amphastar Pharmaceuticals Stock Forecast
NASDAQ: AMPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AMPH analyst consensus
Consensus (7 analysts)
hold
Avg. price target
$24.50-13.27%
- Strong buy 0
- Buy 0
- Hold 6
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Amphastar Pharmaceuticals (2026-11-16), 0 rate the stock a buy or strong buy, 6 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $24.50, with a high estimate of $30.00 and a low estimate of $20.00. The average target implies downside of 13.3% from the current price of $28.25.
The spread between the highest and lowest targets is 50.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for AMPH.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 6 | 86% |
| Sell | 0 | 0% |
| Strong sell | 1 | 14% |
Ratings as of 2026-11-16.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $20.00 | -29.20% |
| Average target | $24.50 | -13.27% |
| High target | $30.00 | +6.19% |